UPC logo

UNIVERSE PHARMACEUTICAL-CL A

UPCNASDAQ
πŸ† #5297 by market capUS Equity
$1.27β€”
Last available close Β· quote unavailable
πŸ””
Track UPC
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ–Ό 14.2%
14dβ–Ό 14.2%
30dβ–Ό 65.8%
ytdβ–Ό 67.0%
1yβ–Ό 64.3%
🏦Market Cap
$682,302
Small Cap
πŸ“ˆRevenue Growth (YoY)
-22.4%
Declining
πŸ“ŠGross Margin
35.9%
Healthy
πŸ’΅FCF Margin
-69.8%
Thin
βš–οΈP/S Ratio
0.0x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
β€”
52-Week Range
$1.05 – $17.96
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
631,761
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$18M
Last Q Revenue
$9M
P/E Ratio
-0.3
P/S Ratio
0.0x
EPS (TTM)
$-3.45
Dividend Yield
0.00%
Dilution (1yr)
+9170.0%
UPC logo

UNIVERSE PHARMACEUTICAL-CL A

UPC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$18Mβ–Ό βˆ’22.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
35.3%β–² +33.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$3Mβ–Ό βˆ’63.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$5Mβ–Ό βˆ’45.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
563Kβ–² +9170.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$24Mβ–² +$3M YoY
StockOtter Β· stockotter.space

About UNIVERSE PHARMACEUTICAL-CL A

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.